DexCom, Inc. Price Today
DexCom, Inc.
DXCM
Healthcare
$34.50B
💰
Market Cap
103.8
💸
Price to Earnings
$0.9
🎉
EPS
+76
🌳
ESG
Consensus Recommendations
Strong_buy Consensus
Buy |
10 |
Strong Buy |
14 |
Hold |
3 |
Sell |
0 |
Strong Sell |
0 |
DXCM Price Forecast Target
89.3 👉 160.0 +79%
DXCM EPS Forecast
0.9 👉 1.6 +86%
Financials
Profit Margin
11 %
Revenue Growth
26.7 %
Dividend
$ 0
Held Percent
0.4% - Insiders
100.7% - Institutions
-1.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $4.0B
-
💰 Blackrock Inc. $3.0B
-
💰 Baillie Gifford and Company $1.5B
-
💰 State Street Corporation $1.5B
-
💰 Sands Capital Management, LLC $1.2B
Stock Ideas
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…📮FAQ
Some Frequently Asked Questions.
The DexCom, Inc. industry is Medical Devices
The DexCom, Inc. sector is Healthcare
The DexCom, Inc. forecasted predicted Price to Earnings PE ratio is 55.8
The DexCom, Inc. Price to Earnings PE ratio is 103.8
The Market Capitalization of DexCom, Inc. is $34.50B
There are total of 383309990 float shares with 100.7% held by Institutions and 0.4% held by insiders
The MDexCom, Inc. forecasted Earnings per Share EPS is $1.6
The DexCom, Inc. Earnings per Share EPS is 0.9
The DexCom, Inc. company has $1883100000 gross profits with 11 profit margins
The DexCom, Inc. Earnings Growth is 0.187% with 0.193% quarterly earnings growth
The DexCom, Inc. Revenue is $3403000064 with 0.267 revenue growth
The price target for DexCom, Inc. stock is $160.0 for the high target and $98.0 for the low target
The consensus analyst recommendations for DexCom, Inc. is Strong_buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for DexCom, Inc. is Strong_buy, with the following breakdown:
- Buy: 10
- Strong Buy: 14
- Hold: 3
- Sell: 0
- Strong Sell: 0
The Beta of DexCom, Inc. is 1.1
The dividend of DexCom, Inc. is $0
The dividend yield of DexCom, Inc. is 0.0041%
The biggest institutional and mutual fund holders of DexCom, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Baillie Gifford and Company
- State Street Corporation
The DexCom, Inc. ESG Score is 76, with the following breakdown:
- E: 5.39
- S: 10.24
- G: 8.08